| Oct 3 |
Bristol-Myers wins FDA nod for Opdivo lung cancer indication
|
| Oct 3 |
U.S. tweaks 2025 Medicare price negotiation process
|
| Oct 3 |
2 Passive Income Stocks to Load Up On in October
|
| Oct 2 |
STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
|
| Oct 1 |
PRME Stock Rises 11.8% on Collaboration With Bristol Myers
|
| Oct 1 |
A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
|
| Oct 1 |
BMS and Prime ink potential $3.5bn deal to develop T cell therapies
|
| Oct 1 |
Read This Before Considering Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming US$0.60 Dividend
|
| Oct 1 |
5 FDA decisions to watch in the fourth quarter
|
| Oct 1 |
Bristol-Myers Squibb Company (BMY) is Driving Growth Through Strategic Acquisitions
|
